高效液相色谱法测定他克莫司眼用乳状液的含量

王延东 唐细兰 叶成添 吴伟

中国药学杂志 ›› 2010, Vol. 45 ›› Issue (3) : 221-222.

PDF(580 KB)
PDF(580 KB)
中国药学杂志 ›› 2010, Vol. 45 ›› Issue (3) : 221-222.
论著

高效液相色谱法测定他克莫司眼用乳状液的含量

  • 王延东,唐细兰,叶成添,吴伟
作者信息 +

Determination of Tacrolimus Ophthalmic Emulsion by HPLC

  • WANG Yan-dong, TANG Xi-lan, YE Cheng-tian, WU Wei
Author information +
文章历史 +

摘要

目的 建立测定他克莫司眼用乳状液含量的高效液相色谱法。方法 采用Diamonsil C18(4.6 mm×250 mm,5 μm)为色谱柱;流动相为乙腈-水-磷酸(600∶400∶1);流速为2.0 mL·min-1;检测波长为215 nm;柱温为50 ℃。结果 他克莫司在6.25~200 mg·L-1内线性关系良好(r=0.999 9),平均回收率为99.35%,RSD为0.81%,方法重现性的RSD为1.04%(n=6)。结论方法专属性强、操作简便、结果准确,可用于测定他克莫司眼用乳状液的含量。

Abstract

OBJECTIVE To establish a HPLC method for the content determination of tacrolimus ophthalmic emulsion. METHODS The separation was performed on a Diamonsil C18 column(4.6 mm×250 mm,5 μm). The mobile phase consisted of acetonitrile- water- phosphonic acid (600∶400∶1) at the flow of 2.0 mL·min-1. The detection wavelength was at 215 nm and column temperature was 50 ℃. RESULTS The calibration curve of tacrolimus was linear within the concentration range of 6.25~200 mg·L-1(r=0.999 9). The average recovery of tacrolimus was 99.35% (RSD=0.81%), and the RSD of the repeatability test was 1.04% (n=6). CONCLUSION The method is simple, quick and specific. It can be used to determine the content of tacrolimus ophthalmic emulsion.

关键词

高效液相色谱法 / 他克莫司 / 眼用乳状液

Key words

HPLC / tacrolimus / ophthalmic emulsion

引用本文

导出引用
王延东 唐细兰 叶成添 吴伟. 高效液相色谱法测定他克莫司眼用乳状液的含量[J]. 中国药学杂志, 2010, 45(3): 221-222
WNG Yn-dong;TNG Xi-ln;YE Cheng-tin;WU Wei. Determination of Tacrolimus Ophthalmic Emulsion by HPLC[J]. Chinese Pharmaceutical Journal, 2010, 45(3): 221-222

参考文献


[1] ATTAS-FOX L, BARKANA Y, ISKHAKOV V, et al.Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open label pilot study[J].Curr Eye Res, 2008,33(7):545-549.
[2] SHI W Y, LIU T, XIE L X, et al.Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft[J].Chin J Ophthalmol(中华眼科杂志),2006,42(4):299-304.
[3] KEIKO O, HIROSHI K, HIROSHI G, et al.Upregulation of neurotrophic factor related gene expression in retina with experimental autoimmune uveoretinitis by intravitreal injection of tacrolimus (FK506)[J].Br J Ophthalmol, 2007,91(11):1537-1540.
[4] FEI W L, CHEN J Q, PANG Z Q, et al.Effects of the FK506 nanoparticles delivery system on a penetrating keratoplasty rejection model in the rat[J]. Chin Ophthal Res(眼科研究),2006,24(2):156-159.
[5] STAATZ C E, TAYLOR P J, TETT S E.Comparison of an ELISA and an LC-MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients[J]. Ther Drug Monit, 2002,24(5):607-615.
[6] FREIRE A, HERMIDA J, TUTOR J C.Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays[J].Ups J Med Sci, 2008,113(1):103-110.
[7] WESTLEY I S, TAYLOR P J, SALM P, et al.Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients[J]. Ther Drug Monit, 2007, 29(5):584-591.
[8] CHEN Y.HPLC Determination of tacrolimus and its related substances[J].Chin J Pharm Anal(药物分析杂志),2008,28(2):309-313.
[9] CHEN J Q, FEI W L, PANG Z Q, et al.Determination and stability of FK506 eye drops by HPLC[J].Chin Ophthal Res(眼科研究),2004, 22(4):355-357.
PDF(580 KB)

Accesses

Citation

Detail

段落导航
相关文章

/